NCT07467772
- Conditions
- Adenosarcoma of the uterus, ESS, Endometrial Neoplasms, +25 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Endometrial Neoplasms
Explore clinical trials studying Endometrial Neoplasms. Study availability and eligibility vary by location and protocol.
19 public trials
4 recruiting studies
Endometrial Neoplasms trial results
NCT02829437
- Conditions
- Endometrial Neoplasms, Endometrial Stromal Tumors, Female Urogenital Diseases, +13 more
- Locations
-
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST Meldola, FC, Italy
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, MI, Italy
- Istituto Europeo di Oncologia Milan, MI, Italy
- Azienda Ospedaliera Universitaria Paolo Giaccone Palermo, PA, Italy
NCT06277154
- Conditions
- Angiosarcoma, Desmoplastic Small Round Cell Tumor, Endometrial Neoplasms, +43 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, China
NCT05080556
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
- Locations
-
- University College London Hospitals London, United Kingdom
NCT03660826
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, not recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, not recruiting
Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.
NCT02598219
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +20 more
- Locations
-
- Polyclinique Urbain V Avignon, France
- Centre Hospitalier Régional Universitaire Besançon, France
- Institut Bergonié Bordeaux, France
- Centre Jean Perrin Clermont-Ferrand, France
Active, not recruiting
Phase I Trial of Defactinib and VS-6766.
NCT03875820
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +27 more
- Locations
-
- The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
- The Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom
- The Royal Marsden NHS Foundation Trust - Gynecology Unit London, United Kingdom
- The Newcastle Upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital Newcastle, United Kingdom
Completed
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
NCT01935934
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
NCT04458597
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +30 more
- Locations
-
- London Regional Cancer Program London, Ontario, Canada